APA (7th ed.) Citation

Pagliarini, S., Beatty, S., Lipkova, B., Garcia, E. P., Reynders, S., Gekkieva, M., . . . Pilz, S. A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study. Wiley.

Chicago Style (17th ed.) Citation

Pagliarini, Sergio, Stephen Beatty, Blandina Lipkova, Eduardo Perez-Salvador Garcia, Stefaan Reynders, Margarita Gekkieva, Abdelkader Si Bouazza, and Stefan Pilz. A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study. Wiley.

MLA (9th ed.) Citation

Pagliarini, Sergio, et al. A 2-Year, Phase IV, Multicentre, Observational Study of Ranibizumab 0.5 mg in Patients with Neovascular Age-Related Macular Degeneration in Routine Clinical Practice: The EPICOHORT Study. Wiley.